Company: NIVFW
Filing Date: 2025-10-10
Form Type: F-1/A
Source: 0001213900-25-098135
Chunk: 117

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-10
Form: F-1/A
Chunk 117
---
 cessation of surrogacy business due to the reorganization of Kyrgyzstan business operation. Cost of revenue NewGenIvf’s cost of revenues decreased by approximately 16.7% from 2,047,970 for the six months period ending June 30, 2024 to 1,705,824 for the six months period ending June 30, 2025. NewGenIvf’s cost of revenue increased by approximately 4.4% from US$3,454,368 in 2023 to 3,606,481 in 2024. Cost of goods sold NewGenIvf’s cost of goods sold increased by approximately 5.8% from US$594,984 in 2023 to US$629,620 in 2024, primarily attributed to the increase on procurement costs. The increase in IVF treatment services, directly leading to increase in cost of goods sold. Clinic costs NewGenIvf’s clinic costs increased by approximately 4.1% from US$2,859,384 in 2023 to US$2,976,861 in 2024, primarily due to the relocation arrangement, certain daily operating schedules stopped, resulting in the clinic’s service being temporarily ceased. Gross profit NewGenIvf’s gross profit for the six months ended June 30, 2025 was $313,804, compared to its gross profit of $638,932 for the nine months ended June 30, 2024, representing a 50.87% decrease from the six months ended June 30, 2024. NewGenIvf’s gross profit increased by approximately 8.6% from US$1,681,785 in 2023 to US$1,826,894 in 2024 to, primarily attributable to a reorganizing of our cooperation model with subcontractors and the increased efficiency of our marketing services, resulting in a decrease in unit service costs per customer, directly leading to increases in gross profit margins. NewGenIvf’s gross margin slightly increased from 32.7% in 2023 to 33.6% in 2024. Operating expenses NewGenIvf’s operating expenses were $3,554,180 and $926,618 for the six months period ended June 30, 2025 and the six months period ended June 30, 2024, respectively. NewGenIvf’s operating expenses increased by approximately 82.2% from US$1,639,543 in